Literature DB >> 30814340

Patients with autism spectrum disorders display reproducible functional connectivity alterations.

Štefan Holiga1, Joerg F Hipp2, Christopher H Chatham2, Pilar Garces2, Will Spooren2, Xavier Liogier D'Ardhuy2, Alessandro Bertolino2,3, Céline Bouquet2, Jan K Buitelaar4, Carsten Bours4, Annika Rausch4, Marianne Oldehinkel4,5, Manuel Bouvard6, Anouck Amestoy6, Mireille Caralp7, Sonia Gueguen8, Myriam Ly-Le Moal9, Josselin Houenou10,11, Christian F Beckmann4, Eva Loth12, Declan Murphy12, Tony Charman12, Julian Tillmann12,13, Charles Laidi10, Richard Delorme14,15, Anita Beggiato14,15, Alexandru Gaman10, Isabelle Scheid10, Marion Leboyer10, Marc-Antoine d'Albis10,11, Jeff Sevigny2, Christian Czech2, Federico Bolognani2,16, Garry D Honey2, Juergen Dukart1,17,18.   

Abstract

Despite the high clinical burden, little is known about pathophysiology underlying autism spectrum disorder (ASD). Recent resting-state functional magnetic resonance imaging (rs-fMRI) studies have found atypical synchronization of brain activity in ASD. However, no consensus has been reached on the nature and clinical relevance of these alterations. Here, we addressed these questions in four large ASD cohorts. Using rs-fMRI, we identified functional connectivity alterations associated with ASD. We tested for associations of these imaging phenotypes with clinical and demographic factors such as age, sex, medication status, and clinical symptom severity. Our results showed reproducible patterns of ASD-associated functional hyper- and hypoconnectivity. Hypoconnectivity was primarily restricted to sensory-motor regions, whereas hyperconnectivity hubs were predominately located in prefrontal and parietal cortices. Shifts in cortico-cortical between-network connectivity from outside to within the identified regions were shown to be a key driver of these abnormalities. This reproducible pathophysiological phenotype was partially associated with core ASD symptoms related to communication and daily living skills and was not affected by age, sex, or medication status. Although the large effect sizes in standardized cohorts are encouraging with respect to potential application as a treatment and for patient stratification, the moderate link to clinical symptoms and the large overlap with healthy controls currently limit the usability of identified alterations as diagnostic or efficacy readout.
Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Year:  2019        PMID: 30814340     DOI: 10.1126/scitranslmed.aat9223

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  29 in total

1.  Default mode-visual network hypoconnectivity in an autism subtype with pronounced social visual engagement difficulties.

Authors:  Michael V Lombardo; Lisa Eyler; Adrienne Moore; Michael Datko; Cynthia Carter Barnes; Debra Cha; Eric Courchesne; Karen Pierce
Journal:  Elife       Date:  2019-12-17       Impact factor: 8.140

2.  Advances in the identification and validation of autism biomarkers.

Authors:  Bethany F M Oakley; Eva Loth; Emily J H Jones; Christopher H Chatham; Declan G Murphy
Journal:  Nat Rev Drug Discov       Date:  2022-10       Impact factor: 112.288

3.  Effectivity of ILF Neurofeedback on Autism Spectrum Disorder-A Case Study.

Authors:  Alexandra Rauter; Horst Schneider; Wolfgang Prinz
Journal:  Front Hum Neurosci       Date:  2022-06-09       Impact factor: 3.473

4.  Giant ankyrin-B mediates transduction of axon guidance and collateral branch pruning factor sema 3A.

Authors:  Blake A Creighton; Simone Afriyie; Deepa Ajit; Cristine R Casingal; Kayleigh M Voos; Joan Reger; April M Burch; Eric Dyne; Julia Bay; Jeffrey K Huang; E S Anton; Meng-Meng Fu; Damaris N Lorenzo
Journal:  Elife       Date:  2021-11-23       Impact factor: 8.713

5.  Compensatory Hippocampal Recruitment Supports Preserved Episodic Memory in Autism Spectrum Disorder.

Authors:  Jeremy Hogeveen; Marie K Krug; Raphael M Geddert; J Daniel Ragland; Marjorie Solomon
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2019-09-05

6.  Microstructure of the Dorsal Anterior Cingulum Bundle in Very Preterm Neonates Predicts the Preterm Behavioral Phenotype at 5 Years of Age.

Authors:  Rebecca G Brenner; Christopher D Smyser; Rachel E Lean; Jeanette K Kenley; Tara A Smyser; Peppar E P Cyr; Joshua S Shimony; Deanna M Barch; Cynthia E Rogers
Journal:  Biol Psychiatry       Date:  2020-06-27       Impact factor: 13.382

7.  Imbalanced social-communicative and restricted repetitive behavior subtypes of autism spectrum disorder exhibit different neural circuitry.

Authors:  Natasha Bertelsen; Isotta Landi; Richard A I Bethlehem; Jakob Seidlitz; Elena Maria Busuoli; Veronica Mandelli; Eleonora Satta; Stavros Trakoshis; Bonnie Auyeung; Prantik Kundu; Eva Loth; Guillaume Dumas; Sarah Baumeister; Christian F Beckmann; Sven Bölte; Thomas Bourgeron; Tony Charman; Sarah Durston; Christine Ecker; Rosemary J Holt; Mark H Johnson; Emily J H Jones; Luke Mason; Andreas Meyer-Lindenberg; Carolin Moessnang; Marianne Oldehinkel; Antonio M Persico; Julian Tillmann; Steve C R Williams; Will Spooren; Declan G M Murphy; Jan K Buitelaar; Simon Baron-Cohen; Meng-Chuan Lai; Michael V Lombardo
Journal:  Commun Biol       Date:  2021-05-14

Review 8.  Structural, Functional, and Molecular Imaging of Autism Spectrum Disorder.

Authors:  Xiaoyi Li; Kai Zhang; Xiao He; Jinyun Zhou; Chentao Jin; Lesang Shen; Yuanxue Gao; Mei Tian; Hong Zhang
Journal:  Neurosci Bull       Date:  2021-03-29       Impact factor: 5.271

9.  Distinct effects of prematurity on MRI metrics of brain functional connectivity, activity, and structure: Univariate and multivariate analyses.

Authors:  Antonio M Chiarelli; Carlo Sestieri; Riccardo Navarra; Richard G Wise; Massimo Caulo
Journal:  Hum Brain Mapp       Date:  2021-05-06       Impact factor: 5.038

10.  Modulation of striatal functional connectivity differences in adults with and without autism spectrum disorder in a single-dose randomized trial of cannabidivarin.

Authors:  Charlotte M Pretzsch; Dorothea L Floris; Bogdan Voinescu; Malka Elsahib; Maria A Mendez; Robert Wichers; Laura Ajram; Glynis Ivin; Martin Heasman; Elise Pretzsch; Steven Williams; Declan G M Murphy; Eileen Daly; Gráinne M McAlonan
Journal:  Mol Autism       Date:  2021-07-01       Impact factor: 7.509

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.